Table 3 Correlation between HBV serological markers in NA-treated patients
From: Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
HBV DNA | HBsAg | |
|---|---|---|
Week 12 of NA therapy (n = 59) | ||
HBV RNA | 0.640(P < 0.05*) | 0.440(P < 0.05*) |
HBV DNA | – | 0.519(P < 0.05*) |
Week 24 of NA therapy (n = 46) | ||
HBV RNA | 0.715(P < 0.05*) | 0.438(P < 0.05*) |
HBV DNA | – | 0.398(P < 0.05*) |
Week 48 of NA therapy (n = 30) | ||
HBV RNA | 0.656(P < 0.05*) | 0.216(P = 0.252) |
HBV DNA | – | 0.094(P = 0.622) |